Connect with us

Announcements

Royal CBD Adds Three New CBD Products; High-Potency Cannabidiol, Gummy Edibles and SoftGels

Emma Jay

Published

on

Royal CBD Adds Three New CBD Products; High-Potency Cannabidiol, Gummy Edibles and SoftGels

Royal CBD is offering three new products with the expansion of its CBD product lineup. The company aims to offer high-quality, full-spectrum hemp extracts. They use organically grown hemp along with high-grade MCT oil to keep their product simple and pure. This summer, they will be adding a high-potency CBD oil which will be two-times the potency of its current highest potency option. It is a 1000mg full spectrum CBD that delivers 1mg of CBD per drop. Royal CBD will be adding two new flavors of mint and citrus to add to their unflavored oils.

Their oils will also be available in soft gel capsules providing convenience for transport or for those who do not like the taste or texture of oils. The same high-quality hemp extract will be used, and it will provide 25mg of CBD per capsule. Finally, they will be adding CBD gummy supplements that contain 10mg of CBD per gummy. There is, however, some question around the consistency of CBD gummies, but Royal CBD ensures that they will be using a pharmaceutical technique to accurately measure and distribute the CBD. It is more costly upfront but will ensure the quality of the end product.

Emma Jay is one of the most esteemed suppliers of COR cannabis content who loves to find facts and figures as well as stuff plenty of statistics and tidbits backed by research. Stemming with authenticity as a Certified HIPAA Professional in healthcare, Section 504 Coordinator Certificate in Legal and Certified Housing Asset Manager in Real Estate. Boasting over a decade-long stint in community healthcare, EJ will now be helping carry the COR torch into the future.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Join Us On Facebook

Trending CBD News

TimesofCBD always fact checks sources and aims for the best accuracy in the reporting curated cannabis content consisting of the latest CBD news, user guides and product health research. Quality is the priority, but we are not eligible to be liable as everything here is for educational, informational purposes only. Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.

What Is CBD?

Copyright © 2019 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends: Telegram